Prevalence of hepatitis C virus infection in Slovakia;Prevalencia infekcie vírusom hepatitídy C v Slovenskej republike

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 13, Issue 2, 2007, Pages 54-58

  Schréter, Ivan ^a   Kristian, P ^a   Klement, C ^b   Kohutova D ^b   Jarcuska P ^a   Madarova L ^b   Avdicova M ^b   Maderova E ^b  

^a Med Faculty of Safarik University   (Slovakia)

^b Regionálny Úrad Verejného Zdravotníctva ^*  (Slovakia)

Author keywords

Anti HCV; HCV RNA; Hepatitis C.; Prevalence; Slovakia

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; QUALITATIVE ANALYSIS; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; SLOVAKIA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SLOVAKIA;

EID: 34547603633     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
2. Mansell CJ, Locarnini SA: Epidemiology of Hepatitis C in the East. Semin Liver Dis. 1995;15:15-32.
3. Thomson BJ, Finch RG: Hepatitis C virus infection. Clin Microbiol Infect. 2005;11:86-94.
4. Hugecová D, Schréter I, Adamkovičová E, Jarčuška P: Hepatitis C virus Infection and Blood Donors in Eastern Slovakia. XI. International Congress of Liver Diseases, Basel, Falk Symposium No.115, 1999:94.
5. Schréter I, Hugecová D, Kristian P, Karabová E: Anti-HCV Prevalence in Different Groups in Eastern Slovakia. XI. International Congress of Liver Diseases, Basel, Falk Symposium No.115, 1999:154.
6. Gazdik F, Pijak M, Kazar J, Laktis K, Gazdikova K, Kuba D: Hepatitis C virus prevalence among general population and risk groups in the Slovak Republic. Hepatology 2001;34,4, Pt.2: AASLD 52nd Annual Meeting: 559A, abstract 1547.
7. Zobair MY, McHutchison JG: Serological Test for HCV Infection. Viral Hepatitis. 1996;2:161-173.
8. Tillman HL, Manns MP: Mode of hepatitis C infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci. 1996;41:27S-40S.
9. Trépo CH, Bailly F. Mangnitude and Management of HCV infection in France. Dig Dis Sci. 1996;41:22-26.
10. Papaevangelou G. Perspestives on viral hepatitis elimination in Europe. In: Nishioka K, Suzuki H, Mishiro S, Oda T (Eds.). Viral hepatitis and liver disease. Tokyo, Springer Verlag. 1993:435-438.
11. Nishioka K, Mishiro S, Yoshizawa H. Hepatitis C virus infection in the general population of Japan: Past and future. Viral Hepatitis Reviews. 1996;2:199-203.
12. Lauer GM, Walker BD: Hepatitis C Virus Infection. Medical Progress. N Engl J Med. 2001;345:41-51.
13. WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis prevention Board, Antwerp, Belgium. J Viral Hepat, 1999;6:35-47.
14. Sy T, Jamal MM: Epidemiology of Hepatitis C Virus (HCV) Infection. Int J Med Sci. 2006;3:41-46.
15. Němeček V: Sérologický přehled ČR v roce 2001 - virová hepatitida A, B, C. Zprávy CEM, září 2003;12(příloha 1):55-61.